| |||||||||||||||
Substance Abuse Treatment Advisory: Naltrexone
The Center for Substance Abuse Treatment's (CSAT's) latest Substance Abuse Treatment Advisory, Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence (Spring 2007, Volume 6, Issue 1) is available now! In April 2006, the U.S. Food and Drug Administration approved a new extended-release injectable formulation of naltrexone (Vivitrol®) for the treatment of alcohol dependence. This issue answers questions treatment providers, particularly counselors and program administrators, may have about injectable naltrexone. |
Act Now
Order today! Contact SAMHSA's Health Information Network:
1-877-SAMHSA-7 1-800-487-4889 (TDD) For More Information |
||||||||||||||
Be Sure To Check Out These Materials |
|||||||||||||||